Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in NRXS — Neuraxis, INC

CIK 73124 CHICAGO, IL
Back to NRXS Full portfolio

Position in NRXS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$168,736
+$33,442 QoQ
Shares Held
23,083
+26.3% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 32 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. NRXS ranks #329 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in NRXS

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $168,736 23,083
2026-03-31 $135,294 18,283
2025-12-31 $94,186 20,746